MAP2K7 and neoplasm: These results connect deregulated activation of Ras/MEK/ERK signaling caused by absence of neurofibromin with complex I inhibition, in keeping with a reported role of oncogenic Ras in orchestrating the metabolic rewiring of tumor cells [6].